IL161335D0 - Coating of stents for preventing restenosis - Google Patents

Coating of stents for preventing restenosis


Publication number
IL161335D0 IL16133502A IL16133502A IL161335D0 IL 161335 D0 IL161335 D0 IL 161335D0 IL 16133502 A IL16133502 A IL 16133502A IL 16133502 A IL16133502 A IL 16133502A IL 161335 D0 IL161335 D0 IL 161335D0
Prior art keywords
preventing restenosis
Prior art date
Application number
Original Assignee
Hemoteq Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to DE10150340 priority Critical
Priority to DE10157610 priority
Application filed by Hemoteq Gmbh filed Critical Hemoteq Gmbh
Priority to PCT/DE2002/003941 priority patent/WO2003034944A1/en
Publication of IL161335D0 publication Critical patent/IL161335D0/en



The invention relates to stents with at least one hemocompatible coating which contains an antiproliferative, antiinflammatory and/or antithrombotic active agent, methods for the preparation of said stents as well as the use of said stents for the prevention of restenosis.
IL16133502A 2001-10-15 2002-10-15 Coating of stents for preventing restenosis IL161335D0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
DE10150340 2001-10-15
DE10157610 2001-11-26
PCT/DE2002/003941 WO2003034944A1 (en) 2001-10-15 2002-10-15 Coating of stents for preventing restenosis

Publications (1)

Publication Number Publication Date
IL161335D0 true IL161335D0 (en) 2004-09-27



Family Applications (2)

Application Number Title Priority Date Filing Date
IL16133502A IL161335D0 (en) 2001-10-15 2002-10-15 Coating of stents for preventing restenosis
IL16133504A IL161335A (en) 2001-10-15 2004-04-08 Coating of stents for preventing restenosis

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL16133504A IL161335A (en) 2001-10-15 2004-04-08 Coating of stents for preventing restenosis

Country Status (14)

Country Link
US (1) US8679520B2 (en)
EP (1) EP1435877B1 (en)
JP (1) JP4549059B2 (en)
KR (1) KR100679990B1 (en)
CN (1) CN1568166A (en)
AT (1) AT428372T (en)
BR (1) BR0213279A (en)
CA (1) CA2462723C (en)
DE (2) DE10294792D2 (en)
DK (1) DK1435877T3 (en)
ES (1) ES2327031T3 (en)
IL (2) IL161335D0 (en)
WO (1) WO2003034944A1 (en)
ZA (1) ZA200402839B (en)

Families Citing this family (125)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6346510B1 (en) * 1995-10-23 2002-02-12 The Children's Medical Center Corporation Therapeutic antiangiogenic endostatin compositions
US7399480B2 (en) * 1997-09-26 2008-07-15 Abbott Laboratories Methods of administering tetrazole-containing rapamycin analogs with other therapeutic substances using medical devices
US7220276B1 (en) * 2000-03-06 2007-05-22 Surmodics, Inc. Endovascular graft coatings
IL161335D0 (en) 2001-10-15 2004-09-27 Hemoteq Gmbh Coating of stents for preventing restenosis
BR0311446A (en) * 2002-05-09 2005-03-15 Hemoteq Gmbh Compounds and processes for coating surfaces hemocompatìvel
AU2004229478B2 (en) * 2003-04-10 2009-12-24 3M Innovative Properties Company Delivery of immune response modifier compounds
US7407955B2 (en) 2002-08-21 2008-08-05 Boehringer Ingelheim Pharma Gmbh & Co., Kg 8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions
BRPI0408891A (en) * 2003-03-28 2006-04-11 Kosan Biosciences Inc devices, methods and compositions for preventing restenosis
US20080215137A1 (en) * 2003-04-30 2008-09-04 Boston Scientific Scimed, Inc. Therapeutic driving layer for a medical device
JP2007526009A (en) * 2003-06-19 2007-09-13 バスキュラー セラピーズ エルエルシー Medical devices and methods for modulating the tissue response to vascular closure orthosis
DE102004020856A1 (en) * 2003-09-29 2005-04-14 Hemoteq Gmbh Medical product coated with biostable layer of polysulfone, useful particularly as stent for preventing restenosis, controls kinetics of release of incorporated active agents, e.g. antiproliferative agents
US20090232866A1 (en) * 2003-10-07 2009-09-17 Mariann Pavone-Gyongyosi Oligopeptides as coating material for medical products
US20050129731A1 (en) * 2003-11-03 2005-06-16 Roland Horres Biocompatible, biostable coating of medical surfaces
FR2861993B1 (en) * 2003-11-06 2006-01-20 Jean Claude Rigaud Complex molecular anti restenosis endoprosthesis for intracoronary
WO2005049105A2 (en) * 2003-11-10 2005-06-02 Angiotech International Ag Medical implants and anti-scarring agents
WO2005075003A1 (en) * 2004-01-21 2005-08-18 Medtronic Vascular Inc. Implantable medical devices for treating or preventing restenosis
US8828416B2 (en) * 2004-03-09 2014-09-09 Cordis Corporation Local vascular delivery of topotecan in combination with rapamycin to prevent restenosis following vascular injury
US8685431B2 (en) * 2004-03-16 2014-04-01 Advanced Cardiovascular Systems, Inc. Biologically absorbable coatings for implantable devices based on copolymers having ester bonds and methods for fabricating the same
US7550443B2 (en) * 2004-03-26 2009-06-23 Surmodics, Inc. Process and systems for biocompatible surfaces
WO2005097223A1 (en) * 2004-03-26 2005-10-20 Surmodics, Inc. Composition and method for preparing biocompatible surfaces
JP2008510726A (en) * 2004-08-20 2008-04-10 エントレメッド インコーポレイテッド Compositions and methods comprising proteinase activated receptor antagonist
CN101052362A (en) * 2004-09-08 2007-10-10 株式会社钟化 Organism indwelling support
CN101933923A (en) * 2004-11-05 2011-01-05 赛福伦公司 Cancer treatments
DE102004054054A1 (en) 2004-11-05 2006-05-11 Boehringer Ingelheim Pharma Gmbh & Co. Kg A process for preparing chiral 8- (3-amino-piperidin-1-yl) -xanthines
US8436190B2 (en) * 2005-01-14 2013-05-07 Cephalon, Inc. Bendamustine pharmaceutical compositions
EP3345631A1 (en) * 2005-02-18 2018-07-11 Abraxis BioScience, LLC Drugs with improved hydrophobicity for incorporation in medical devices
EP1853278A4 (en) * 2005-02-18 2011-12-28 Cartilix Inc Glucosamine materials
US20060222627A1 (en) * 2005-03-30 2006-10-05 Andrew Carter Optimizing pharmacodynamics of therapeutic agents for treating vascular tissue
AU2006270221B2 (en) 2005-07-15 2012-01-19 Micell Technologies, Inc. Polymer coatings containing drug powder of controlled morphology
US7632304B2 (en) * 2005-09-07 2009-12-15 Rbkpark Llc Coronary stent
US9233012B2 (en) 2005-09-07 2016-01-12 RBKPark, LLC Medical stent
KR100778020B1 (en) * 2005-10-24 2007-11-28 사회복지법인 삼성생명공익재단 Vascular stent which is specially designed for the multiple drug loading and better drug elution
US20070104753A1 (en) * 2005-11-04 2007-05-10 Aiden Flanagan Medical device with a coating comprising an active form and an inactive form of therapeutic agent(s)
EP1951332A1 (en) * 2005-11-10 2008-08-06 Schering Aktiengesellschaft Reduction of restenosis
US20070207183A1 (en) 2006-01-05 2007-09-06 Med Institute, Inc. Zein coated medical device
KR100706032B1 (en) * 2006-01-07 2007-04-04 장양수 A genotyping kit for surgical operation of paclitaxel eluting stent
WO2007127363A2 (en) 2006-04-26 2007-11-08 Micell Technologies, Inc. Coatings containing multiple drugs
PE02352011A1 (en) 2006-05-04 2011-04-14 Boehringer Ingelheim Int pharmaceutical combinations comprising metformin and linagliptin
CA2651089C (en) 2006-05-04 2018-02-20 Peter Sieger A polymeric form of 1-((4-methyl-quinazolin-2-yl)methyl)-3-7-(2-butyn-1-yl)-8-(3-(r)-aminopiperidin-1-yl)xanthine
KR100778654B1 (en) * 2006-05-09 2007-11-28 전남대학교산학협력단 Alpha-Iipoic acid Coating Method of stent for blood vessel
EP2037981B1 (en) 2006-06-13 2019-05-08 Alchimedics Drug eluting stent with a biodegradable release layer attached with an electro-grafted primer coating
US20080124404A1 (en) * 2006-06-19 2008-05-29 Jingwen Liu Hypolipidemic and/or hypocholesteremic compounds obtainable from the goldenseal plant
US9192697B2 (en) 2007-07-03 2015-11-24 Hemoteq Ag Balloon catheter for treating stenosis of body passages and for preventing threatening restenosis
NZ592795A (en) * 2006-07-03 2012-03-30 Hemoteq Ag Manufacture, method, and use of active substance-releasing medical products for permanently keeping blood vessels open
US20080181928A1 (en) * 2006-12-22 2008-07-31 Miv Therapeutics, Inc. Coatings for implantable medical devices for liposome delivery
US9737642B2 (en) 2007-01-08 2017-08-22 Micell Technologies, Inc. Stents having biodegradable layers
WO2008086490A2 (en) * 2007-01-11 2008-07-17 Robert Lamar Bjork, Jr Multiple drug-eluting coronary artery stent for percutaneous coronary artery intervention
US20080177373A1 (en) * 2007-01-19 2008-07-24 Elixir Medical Corporation Endoprosthesis structures having supporting features
DE112008000881A5 (en) 2007-01-21 2010-01-21 Hemoteq Ag Medical device for treating obstructions of body passages and prevent the threat of re-closures
CN101007187B (en) * 2007-01-26 2014-01-01 复旦大学附属华山医院 Preparation method of composite drug-eluting stent and its drug coated layer
US20080241215A1 (en) * 2007-03-28 2008-10-02 Robert Falotico Local vascular delivery of probucol alone or in combination with sirolimus to treat restenosis, vulnerable plaque, aaa and stroke
WO2008128567A1 (en) * 2007-04-19 2008-10-30 Medovent Gmbh Device made at least partially of n-acetylchitosan with controlled biodissolution
US8133553B2 (en) 2007-06-18 2012-03-13 Zimmer, Inc. Process for forming a ceramic layer
US8309521B2 (en) 2007-06-19 2012-11-13 Zimmer, Inc. Spacer with a coating thereon for use with an implant device
KR20100085179A (en) 2007-09-04 2010-07-28 가부시키가이샤 니혼 스텐토 테크놀로지 Stent for controlled drug release
WO2009036250A1 (en) * 2007-09-12 2009-03-19 Cook Incorporated Enhanced remodelable materials for occluding bodily vessels and related methods and systems
FR2921661B1 (en) * 2007-10-01 2013-05-31 Centre Nat Rech Scient Hybrid organic inorganic solid is surface modified.
US20090092664A1 (en) * 2007-10-08 2009-04-09 University Of Kentucky Research Foundation Polymer-metal chelator conjugates and uses thereof
US8608049B2 (en) * 2007-10-10 2013-12-17 Zimmer, Inc. Method for bonding a tantalum structure to a cobalt-alloy substrate
US20110230973A1 (en) * 2007-10-10 2011-09-22 Zimmer, Inc. Method for bonding a tantalum structure to a cobalt-alloy substrate
EP2211926A2 (en) * 2007-10-10 2010-08-04 Miv Therapeutics Inc. Lipid coatings for implantable medical devices
WO2009051780A1 (en) * 2007-10-19 2009-04-23 Micell Technologies, Inc. Drug coated stents
EP2214747A2 (en) * 2007-11-20 2010-08-11 Cook Incorporated Controlled drug delivery using a zein layer modified with levulinic acid
US20090187256A1 (en) * 2008-01-21 2009-07-23 Zimmer, Inc. Method for forming an integral porous region in a cast implant
US20090198286A1 (en) * 2008-02-05 2009-08-06 Zimmer, Inc. Bone fracture fixation system
WO2009116750A2 (en) * 2008-03-17 2009-09-24 이화여자대학교 산학협력단 Composition for the coating of stent for preventing restenosis and stent manufactured using same
AR072777A1 (en) 2008-03-26 2010-09-22 Cephalon Inc solid forms of bendamustine hydrochloride
AR071175A1 (en) 2008-04-03 2010-06-02 Boehringer Ingelheim Int pharmaceutical composition comprising an inhibitor of dipeptidyl peptidase-4 (DPP4) and a companion drug
JP5608160B2 (en) 2008-04-17 2014-10-15 ミセル テクノロジーズ、インコーポレイテッド Stent with a bioabsorbable layer
EP2285901A1 (en) 2008-05-06 2011-02-23 Metabolix, Inc. Biodegradable polyester blends
AU2009244790B2 (en) * 2008-05-09 2013-09-12 Duke University Treatment for diseases relying on discovery that thioredoxin mediates nitric oxide release in cells
EP2313122B1 (en) 2008-07-17 2019-03-06 Micell Technologies, Inc. Drug delivery medical device
US9510856B2 (en) 2008-07-17 2016-12-06 Micell Technologies, Inc. Drug delivery medical device
KR20190016601A (en) 2008-08-06 2019-02-18 베링거 인겔하임 인터내셔날 게엠베하 Treatment for diabetes in patients inappropriate for metformin therapy
WO2010036702A1 (en) * 2008-09-25 2010-04-01 Cephalon, Inc. Liquid formulations of bendamustine
WO2010072776A1 (en) 2008-12-23 2010-07-01 Boehringer Ingelheim International Gmbh Salt forms of organic compound
KR20110110293A (en) * 2009-01-15 2011-10-06 세파론, 인코포레이티드 Novel forms of bendamustine free base
US20100209475A1 (en) * 2009-02-19 2010-08-19 Biomet Manufacturing Corp. Medical implants having a drug delivery coating
US8968818B2 (en) * 2009-02-21 2015-03-03 Covidien Lp Medical devices having activated surfaces
JP5597625B2 (en) 2009-03-02 2014-10-01 株式会社日本ステントテクノロジー Drug-eluting stents
CA2757276C (en) 2009-04-01 2017-06-06 Micell Technologies, Inc. Coated stents
CA2759015C (en) 2009-04-17 2017-06-20 James B. Mcclain Stents having controlled elution
EP3064230B1 (en) 2009-07-10 2019-04-10 Boston Scientific Scimed, Inc. Use of nanocrystals for a drug delivery balloon
WO2011008393A2 (en) * 2009-07-17 2011-01-20 Boston Scientific Scimed, Inc. Nucleation of drug delivery balloons to provide improved crystal size and density
US9913832B2 (en) * 2009-10-12 2018-03-13 Rajabrata Sarkar Accelerating thrombus resolution through augmentation of p53 activity
KR20170136017A (en) 2009-11-27 2017-12-08 베링거 인겔하임 인터내셔날 게엠베하 Treatment of genotyped diabetic patients with dpp-iv inhibitors such as linagliptin
WO2011081712A1 (en) * 2009-12-31 2011-07-07 Boston Scientific Scimed, Inc. Cryo activated drug delivery and cutting balloons
EP2547371A1 (en) * 2010-03-15 2013-01-23 Ferrosan Medical Devices A/S A method for promotion of hemostasis and/or wound healing
WO2011133655A1 (en) 2010-04-22 2011-10-27 Micell Technologies, Inc. Stents and other devices having extracellular matrix coating
EA201201508A1 (en) 2010-05-05 2013-05-30 Бёрингер Ингельхайм Интернациональ Гмбх Combined therapy
US8920486B2 (en) 2010-05-18 2014-12-30 RBKPark, LLC Medical device
EP3124041A1 (en) 2010-06-24 2017-02-01 Boehringer Ingelheim International GmbH Diabetes therapy
WO2012031236A1 (en) 2010-09-02 2012-03-08 Boston Scientific Scimed, Inc. Coating process for drug delivery balloons using heat-induced rewrap memory
US9034883B2 (en) 2010-11-15 2015-05-19 Boehringer Ingelheim International Gmbh Vasoprotective and cardioprotective antidiabetic therapy
ES2646191T3 (en) 2011-03-09 2017-12-12 Csl Behring Gmbh Factor XII inhibitors for administration with medical procedures involving contact with artificial surfaces
KR101064214B1 (en) * 2011-04-08 2011-09-14 강원대학교산학협력단 Drug eluting stent with chitosan coating layer and method of making the same
KR20120135689A (en) * 2011-06-07 2012-12-17 (주) 태웅메디칼 Manufacturing method for drug releasing stent coated with the coating agent and thereny coating agent for drug releasing stent
WO2013012689A1 (en) 2011-07-15 2013-01-24 Micell Technologies, Inc. Drug delivery medical device
JP5876150B2 (en) 2011-07-15 2016-03-02 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング Substituted quinazoline, use of these these preparation and pharmaceutical compositions
US8669360B2 (en) 2011-08-05 2014-03-11 Boston Scientific Scimed, Inc. Methods of converting amorphous drug substance into crystalline form
US9056152B2 (en) 2011-08-25 2015-06-16 Boston Scientific Scimed, Inc. Medical device with crystalline drug coating
CN102397119A (en) * 2011-09-29 2012-04-04 微创医疗器械(上海)有限公司 Interventional medical appliance and manufacturing method thereof
CN102499798A (en) * 2011-09-29 2012-06-20 微创医疗器械(上海)有限公司 Interventional medical device and preparation method thereof
US10188772B2 (en) 2011-10-18 2019-01-29 Micell Technologies, Inc. Drug delivery medical device
US9555001B2 (en) 2012-03-07 2017-01-31 Boehringer Ingelheim International Gmbh Pharmaceutical composition and uses thereof
EP2849755A1 (en) 2012-05-14 2015-03-25 Boehringer Ingelheim International GmbH A xanthine derivative as dpp -4 inhibitor for use in the treatment of podocytes related disorders and/or nephrotic syndrome
WO2013174767A1 (en) 2012-05-24 2013-11-28 Boehringer Ingelheim International Gmbh A xanthine derivative as dpp -4 inhibitor for use in modifying food intake and regulating food preference
US9475930B2 (en) 2012-08-17 2016-10-25 Metabolix, Inc. Biobased rubber modifiers for polymer blends
CN102861364A (en) * 2012-10-16 2013-01-09 天津市第三中心医院 Preparation method and application of dexamethasone sodium phosphate-sodium alga acid composite slow-release coating
CN102872484A (en) * 2012-10-16 2013-01-16 天津市第三中心医院 Preparation method of dexamethasone sodium phosphate composite sustained-release coating and application thereof
AU2014224599B2 (en) 2013-03-08 2018-11-08 Csl Behring Gmbh Treatment and prevention of remote ischemia-reperfusion injury
US9545301B2 (en) 2013-03-15 2017-01-17 Covidien Lp Coated medical devices and methods of making and using same
KR20180059584A (en) 2013-05-15 2018-06-04 미셀 테크놀로지즈, 인코포레이티드 Bioabsorbable biomedical implants
WO2014198906A1 (en) * 2013-06-14 2014-12-18 Boehringer Ingelheim International Gmbh Dpp-4 inhibitors for treating diabetes and its complications
ES2628210T3 (en) 2013-11-14 2017-08-02 Pfm Medical Titanium Gmbh Polyurethane having an antithrombogenic coating
US9668890B2 (en) 2013-11-22 2017-06-06 Covidien Lp Anti-thrombogenic medical devices and methods
EP3110449A1 (en) 2014-02-28 2017-01-04 Boehringer Ingelheim International GmbH Medical use of a dpp-4 inhibitor
US9492594B2 (en) * 2014-07-18 2016-11-15 M.A. Med Alliance SA Coating for intraluminal expandable catheter providing contact transfer of drug micro-reservoirs
CN104984412A (en) * 2015-05-12 2015-10-21 湘潭大学 Preparation method for paclitaxel coating on surface of drug balloon
CN105386042B (en) * 2015-11-20 2019-07-09 广西中医药大学 A method of preparing the stainless steel with antibacterial anti-cancer properties
KR101786020B1 (en) 2015-12-24 2017-10-17 전남대학교병원 Stent for inhibiting restenosis by femtosecond laser processing and stimulating re-endothelialization and preparation method thereof
CN105561406A (en) * 2016-02-15 2016-05-11 丹阳纳瑞康纳米科技有限公司 Intravascular stent including composite medicine coating
EP3468562A1 (en) 2016-06-10 2019-04-17 Boehringer Ingelheim International GmbH Combinations of linagliptin and metformin
CN106822117A (en) * 2016-12-21 2017-06-13 陈绍良 Medical application of berberine
CN108186173A (en) * 2018-01-12 2018-06-22 付静 Repairing fusion type heart stent and manufacturing method thereof

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5340932A (en) * 1989-08-18 1994-08-23 Ajorca S.A. Substances with heparin-like structure and their method of production
AR245455A1 (en) 1989-08-18 1994-01-31 Ajorca Sa Procedure for obtaining heparin, partially or totally n-acetylated in the glucosaminic remains, and products thus obtained, excluding pharmaceutical use.
WO1991012779A1 (en) * 1990-02-28 1991-09-05 Medtronic, Inc. Intralumenal drug eluting prosthesis
US5464450A (en) * 1991-10-04 1995-11-07 Scimed Lifesystems Inc. Biodegradable drug delivery vascular stent
US5350800A (en) 1993-01-19 1994-09-27 Medtronic, Inc. Method for improving the biocompatibility of solid surfaces
US5464650A (en) * 1993-04-26 1995-11-07 Medtronic, Inc. Intravascular stent and method
US5380299A (en) * 1993-08-30 1995-01-10 Med Institute, Inc. Thrombolytic treated intravascular medical device
EP0853465A4 (en) * 1995-09-01 1999-10-27 Univ Emory Endovascular support device and method of use
PT876165E (en) 1995-12-18 2006-10-31 Angiotech Biomaterials Corp Compositions of reticulated polymers and processes for their use
CA2258154A1 (en) 1996-06-24 1997-12-31 Prizm Pharmaceuticals, Inc. Heparinized medical devices containing heparin-binding growth factor conjugates
US6174326B1 (en) * 1996-09-25 2001-01-16 Terumo Kabushiki Kaisha Radiopaque, antithrombogenic stent and method for its production
JP3938418B2 (en) 1996-09-25 2007-06-27 テルモ株式会社 Stent
US5980551A (en) * 1997-02-07 1999-11-09 Endovasc Ltd., Inc. Composition and method for making a biodegradable drug delivery stent
WO2000010622A1 (en) 1998-08-20 2000-03-02 Cook Incorporated Coated implantable medical device
DE19908318A1 (en) 1999-02-26 2000-08-31 Michael Hoffmann Hemocompatible surfaces, and processes for their preparation
IL137860D0 (en) 2000-08-15 2001-10-31 Baruch David Coronary membrane covered stent
IL161335D0 (en) 2001-10-15 2004-09-27 Hemoteq Gmbh Coating of stents for preventing restenosis
US6702850B1 (en) * 2002-09-30 2004-03-09 Mediplex Corporation Korea Multi-coated drug-eluting stent for antithrombosis and antirestenosis

Also Published As

Publication number Publication date
EP1435877A1 (en) 2004-07-14
WO2003034944B1 (en) 2003-10-09
CA2462723C (en) 2012-05-01
JP2005506146A (en) 2005-03-03
JP4549059B2 (en) 2010-09-22
WO2003034944A1 (en) 2003-05-01
KR100679990B1 (en) 2007-02-08
BR0213279A (en) 2004-10-26
EP1435877B1 (en) 2009-04-15
US20050060028A1 (en) 2005-03-17
ZA200402839B (en) 2005-06-29
AT428372T (en) 2009-05-15
US8679520B2 (en) 2014-03-25
CN1568166A (en) 2005-01-19
CA2462723A1 (en) 2003-05-01
IL161335A (en) 2010-12-30
ES2327031T3 (en) 2009-10-23
DE50213462D1 (en) 2009-05-28
KR20040050915A (en) 2004-06-17
DE10294792D2 (en) 2004-09-16
DK1435877T3 (en) 2009-08-03

Similar Documents

Publication Publication Date Title
TWI254728B (en) High molecular weight zwitterionic polymers
TW483805B (en) Chemical mechanical polishing systems and methods for their use
HK1051316A1 (en) Methods and compositions for the prevention and treatment of atherosclerosis, restenosis and related disorders
ZA200207420B (en) The treatment of respiratory diseases.
WO2002044156A3 (en) Benzimidazole derivatives useful as tie-2 and/or vegfr-2 inhibitors
ZA200401373B (en) Breath freshening film.
CA2452571A1 (en) Valvular prostheses having metal or pseudometallic construction and methods of manufacture
MX251147B (en) Film-forming compositions for protecting skin from body fluids and articles made therefrom.
AU2001245696A1 (en) Endovascular stent graft
CA2432915A1 (en) Antimicrobial medical devices
MX9704377A (en) Use of pramipexole as a neuroprotective agent.
CA2435306A1 (en) Implants with fk506
HRP20010590A2 (en) Triazole compounds and their use
PL368031A1 (en) Low-e matchable coated articles, and methods of making the same
AU2002225249A1 (en) Use of MoO3 as corrosion inhibitor, and coating composition containing such an inhibitor
IL143086A (en) Bioactive implants, particularly with immunosuppressive, antistenotic and antithrombotic properties, and the production of said implants
WO2006130352A3 (en) Medical devices
HK1057553A1 (en) Imidazolo-5-yl-2-anilino-pyrimidines as agents forthe inhibition of the cell proliferation.
CA2440714A1 (en) Pyrazolopyrimidines as therapeutic agents
MXPA03001642A (en) Self-expanding stent delivery system.
CA2380394A1 (en) Grafted polymers as gas hydrate inhibitors
MXPA04011385A (en) Combination of organic compounds.
WO2002024113A3 (en) Intravascular stent
EP1181903A3 (en) A stent for angioplasty and associated production process
HK1078603A1 (en) Use of moo3 as corrosion inhibitor, and coating composition containing such an inhibitor